Raymed Labs Ltd — Updates, 22-05-2025: Company Update

Cresanto Global Limited (formerly Raymed Labs) has clarified that it is exempt from submitting Related Party Transactions disclosures as its paid-up equity capital is below ₹10 crore and net worth under ₹25 crore. This exemption means the company is not obligated to comply with certain corporate governance provisions related to related party disclosures. This status reflects the company’s current scale and impacts the regulatory reporting burden, offering transparency about its governance framework and compliance requirements for investors.